As of Sep 22
| +0.07 / +0.08%|
The 17 analysts offering 12-month price forecasts for AbbVie have a median target of 78.00, with a high estimate of 107.00 and a low estimate of 60.00. The median estimate represents a -10.84% decrease from the last price of 87.48.
The current consensus among 21 polled investment analysts is to Hold stock in AbbVie. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.